63 Results for "

CSCs

" in MedChemExpress (MCE) Product Catalog:
Products (63)

63 Results for "CSCs" in MCE Product Catalog:

66
66 Publications Verification
Cat. No.: HY-12238
CAS No.: 1127442-82-3
Purity:  99.60%
Synonyms: endo-IWR 1; IWR-1-endo
Target:  

Organoid Wnt

Research Areas:  

Inflammation/Immunology Cancer

IWR-1 (IWR-1-endo) is a tankyrase inhibitor targeting Wnt/β-catenin (IC50 = 180 nM). IWR-1 compromises critical steps of the canonical Wnt signaling, namely translocation of β-catenin to the nucleus and subsequent TCF/LEF activation and expression of Wnt/β-catenin downstream targets. IWR-1 promotes β-catenin phosphorylation by promoting stability of Axin-scaffolded destruction complexes. IWR-1 can be studied in research for anti-tumor purposes, and diseases such as osteosarcoma, colorectal cancer and psoriasis .
loading...
    loading...
12
12 Cited Publications
Cat. No.: HY-12794
CAS No.: 1383716-40-2
Purity:  99.63%
Target:  

PI3K Autophagy

Research Areas:  

Neurological Disease Cancer

Vps34-PIK-III is an orally active and selective VPS34 inhibitor (IC50=18 nM). Vps34-PIK-III effectively inhibits autophagy and can be used as a molecular tool. vps34-PIK-III is also a PI3K inhibitor that inhibits the expression of genes in liver cancer stem cells (CSCs) .
loading...
    loading...
11
11 Cited Publications
Cat. No.: HY-16397A
CAS No.: 834-28-6
Synonyms: Phenethylbiguanide hydrochloride
Phenformin (Phenethylbiguanide) hydrochloride is an orally active biguanide hypoglycemic agent. Phenformin hydrochloride inhibits mitochondrial respiratory chain complex I, leading to an increased AMP/ATP ratio, activation of AMPK, and subsequent inhibition of the mTOR pathway, thereby suppressing cell proliferation, inducing apoptosis and autophagy. Phenformin hydrochloride inhibits cancer stem cells (CSCs) and possesses potent antitumor potential .
loading...
    loading...
11
11 Cited Publications
Cat. No.: HY-106101
CAS No.: 512-64-1
Purity:  98.57%
Synonyms: Quinomycin A; NSC-13502
Research Areas:  

Cancer

Echinomycin (Quinomycin A) is potent small-molecule and cell-permeable inhibitor of hypoxia-inducible factor-1 (HIF-1) DNA-binding activity. Echinomycin selectively inhibits the cancer stem cells (CSCs) with an IC50 of 29.4 pM .
loading...
    loading...
11
11 Cited Publications
Cat. No.: HY-16397
CAS No.: 114-86-3
Synonyms: Phenethylbiguanide
Phenformin (Phenethylbiguanide) is an orally active biguanide hypoglycemic agent. Phenformin inhibits mitochondrial respiratory chain complex I, leading to an increased AMP/ATP ratio, activation of AMPK, and subsequent inhibition of the mTOR pathway, thereby suppressing cell proliferation, inducing apoptosis and autophagy. Phenformin inhibits cancer stem cells (CSCs) and possesses potent antitumor potential .
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-18959
CAS No.: 1144044-02-9
Target:  

β-catenin Wnt

Research Areas:  

Cancer

CWP232228, a highly potent selective Wnt/β-catenin signaling inhibitor, antagonizes binding of β-catenin to T-cell factor (TCF) in the nucleus. CWP232228 suppresses tumor formation and metastasis without toxicity through the inhibition of the growth of breast and liver cancer stem cells (CSCs) .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-B0965
CAS No.: 130-61-0
Thioridazine hydrochloride, an orally active antagonist of the dopamine receptor D2 family proteins, exhibits potent anti-psychotic and anti-anxiety activities. Thioridazine hydrochloride is also a potent inhibitor of PI3K-Akt-mTOR signaling pathways with anti-angiogenic effect. Thioridazine hydrochloride shows antiproliferative and apoptosis induction effects in various types of cancer cells, with specificity on targeting cancer stem cells (CSCs) .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-B0965A
CAS No.: 50-52-2
Thioridazine, an antagonist of the dopamine receptor D2 family proteins, exhibits potent anti-psychotic and anti-anxiety activities. Thioridazine is also a potent inhibitor of PI3K-Akt-mTOR signaling pathways with anti-angiogenic effect. Thioridazine shows antiproliferative and apoptosis induction effects in various types of cancer cells, with specificity on targeting cancer stem cells (CSCs) .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-B0520A
CAS No.: 132-17-2
Synonyms: Benzatropine mesylate; Benzotropine mesylate; Benztropine methanesulfonate
Benztropine mesylate (Benzatropine mesylate) is an orally active and BBB-permeable centrally acting anticholinergic agent that can be used for Parkinson's disease research. Benztropine mesylate is an anti-histamine agent and a dopamine re-uptake inhibitor. Benztropine mesylate is also a human D2 dopamine receptor allosteric antagonist. Benztropine mesylate also has anti-CSCs (cancer stem cells) effects .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-B0520
CAS No.: 86-13-5
Synonyms: Benzatropine; Benzotropine
Research Areas:  

Cancer

Benztropine (Benzatropine; Benzotropine) is an orally active and BBB-permeable centrally acting anticholinergic agent that can be used for Parkinson's disease research . Benztropine is an anti-histamine agent and a dopamine re-uptake inhibitor. Benztropine is also a human D2 dopamine receptor allosteric antagonist. Benztropine mesylate also has anti-CSCs (cancer stem cells) effects .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-122912
CAS No.: 109437-62-9
Purity:  99.15%
Synonyms: ALDH1Ai 673A
ALDH1A inhibitor 673A is an ALDH1A inhibitor with IC50s of 246 nM (ALDH1A1), 230 nM (ALDH1A2), 348 nM (ALDH1A3), respectively. ALDH1A inhibitor 673A has little or no inhibitory effect on other ALDH family members. ALDH1A inhibitor 673A induces necroptotic ovarian cancer stem-like cells (CSCs) death. ALDH1A inhibitor 673A induces DNA double stand breaks in cancer cells. ALDH1A inhibitor 673A can be used for the study of ovarian cancer .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-136541
CAS No.: 1144043-83-3
Purity:  99.80%
Synonyms: Wnt pathway inhibitor 2
Target:  

Wnt Apoptosis

Research Areas:  

Cancer

YB-0158 (Wnt pathway inhibitor 2) is a reverse-turn peptidomimetic and a potent colorectal cancer stem cell (CSC) targeting agent. YB-0158 disrupts Sam68-Src interactions and induces apoptosis in CRC cells. Anti-cancer activities .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-121608
CAS No.: 1088-56-8
Purity:  99.79%
Synonyms: Lumiflavine
Lumiflavin (Lumiflavine), a riboflavine analog, causes significant inhibition of riboflavine uptake. Lumiflavin can effectively reduce the riboflavin enrichment in cancer stem-like cells (CSCs) and sensitize the effect of cisplatin Diamminedichloroplatinum (DDP) on CSCs. Lumiflavin is promising for research of ovarian cancer .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-107553
CAS No.: 1403-36-7
Purity:  95.3%
Target:  

HSP Apoptosis

Research Areas:  

Cancer

Chetomin, an active component of Chaetomium globosum, is a heat shock protein 90/hypoxia-inducible factor 1 alpha (Hsp90/HIF1α) pathway inhibitor. Chetomin is a potent, nontoxic non-small cell lung cancer cancer stem cells (NSCLC CSC)-targeting molecule .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P9974
CAS No.: 1345009-45-1
Synonyms: OMP-18R5

Target:  

Wnt

Research Areas:  

Cancer

Vantictumab (OMP-18R5) is a fully human IgG2 monoclonal antibody. Vantictumab inhibits Wnt pathway signaling by binding to FZD1/2/5/7/8 receptors. Vantictumab can be studied against cancers through direct actions on tumor cells, including CSCs, and effects on the stroma, such as metastatic HER2-negative breast cancer and metastatic pancreatic adenocarcinoma .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-110294
CAS No.: 896795-60-1
Purity:  99.55%
Synonyms: A37
Research Areas:  

Cancer

CM037 is a highly selective and competitive ALDH1A1 inhibitor (IC50=4.6 μM). CM037 blocks the catalytic activity of ALDH1A1, thereby inhibiting the activation of the downstream HIF-1α/VEGF pathway. CM037 is mainly used to study the ALDH1A1-mediated regulation of cancer stem cells (CSCs) and angiogenesis, especially in breast cancer, showing the potential to inhibit tumor angiogenesis and stem cell characteristics .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-107460
CAS No.: 1198408-78-4
Purity:  ≥99.0%
Target:  

Ephrin Receptor

Research Areas:  

Cancer

LDN-211904 oxalate is a potent and reversible EphB3 inhibitor with an IC50 of 79 nM. LDN-211904 oxalate shows good metabolic stability in mouse liver microsomes. LDN-211904 oxalate with Cetuximab (HY-P9905) could be effective in inhibiting STAT3-activated colorectal cancer (CRC) stemness and Cetuximab resistance in CRC .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-110280
CAS No.: 1776116-74-5
Purity:  99.20%
Target:  

HDAC Apoptosis

Research Areas:  

Cancer

MC1742 is a potent HDAC inhibitor, with IC50s of 0.1 μM, 0.11 μM, 0.02 μM, 0.007 μM, 0.61 μM, 0.04 μM and 0.1 μM for HDAC1, HDAC2, HDAC3, HDAC6, HDAC8, HDAC10 and HDAC11, respectively. MC1742 can increase acetyl-H3 and acetyl-tubulin levels and inhibits cancer stem cells growth. MC1742 can induce growth arrest, apoptosis, and differentiation in sarcoma CSC .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-123298
CAS No.: 156951-82-5
Purity:  99.52%
Chrysotoxine is a dual inhibitor of Src/Akt. Chrysotoxine suppresses cancer stem cells (CSCs) phenotypes by down-regulating Src/Akt signaling. Chrysotoxine reduces cell viability and increases apoptosis level in H460 and H23 cells instead of non-tumor cell lines. Chrysotoxine shows rapid excretion and low bioavailability in rats. Chrysotoxine is used in cancer research .
loading...
    loading...
Cat. No.: HY-115630
CAS No.: 2361988-77-2
Purity:  99.82%
Research Areas:  

Cancer

cRIPGBM chloride, an orally active, proapoptotic derivative. cRIPGBM can be generated from glioblastoma multiforme (GBM) cancer stem cells (CSCs). cRIPGBM(chloride) targets to receptor-interacting protein kinase 2 (RIPK2) to induce caspase 1-dependent apoptosis. cRIPGBM(chloride) suppresses the formation of RIPK2/TAK1 (prosurvival complex), and increases the formation of RIPK2/caspase 1 (proapoptotic complex). cRIPGBM(chloride) exerts potent anti-tumor activity in vivo in animal models .
loading...
    loading...